The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis.
- Resource Type
- Article
- Source
- RMD Open; Aug2023, Vol. 9 Issue 3, p1-12, 12p
- Subject
- Language
- ISSN
- 20565933